Biotechnology 121 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotechnology 121. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotechnology 121 Today - Breaking & Trending Today

2024-04-12 | OTCPK:ENZC | Press Release

(2024-04-12 | OTCPK:ENZC) Update on Formulation of New Business Strategy ....

United States , Golden Gate University , San Francisco , Sofiya Grad , Harry Zhabilov , Lachezar Ivanov , Steve Sharabura , Diana Zhabilov , Gaurav Chandra , Steveng Sharabura , American Institute Of Chemical Engineers , Doctor Of Medical Sciences , While Enzolytics Inc , Company Contact , Cornell University , Health Commission , University Of Sofia , Member Of American Chemical Society , University Of Canada , Parliament Of Bulgaria , University Sofia , Enzolytics Inc , Sofia Medical Academy , University Of Chemical Technology Metallurgy , Chief Scientific Officer , American Chemical Society ,

2024-04-01 | NDAQ:SLGL | Press Release | Sol Gel Technologies Ltd

(2024-04-01 | NDAQ:SLGL) Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream ....

United States , New Jersey , Arcutis Biotherapeutics , Padagis Closecurlyquote , Gilad Mamlok , Mori Arkin , Arcutis Closecurlydoublequote , Drug Administration , Company Closecurlyquote , Company Annual Report On Form , Padagis Israel Pharmaceuticals Ltd Closecurlydoublequote , Us District Court , Arcutis Biotherapeutics Inc , Gel Technologies Ltd , Exchange Commission , Gel Technologies , Padagis Israel Pharmaceuticals Ltd , Sol Gel Closecurlyquote , Abbreviated New Drug Application , Roflumilast Cream , Padagis Roflumilast Cream , Zoryve Cream , Though Sol Gel , Executive Chairman , Private Securities Litigation Reform Act , Annual Report ,

2024-02-14 | NDAQ:GLSI | Press Release | Greenwich Lifesciences Inc

(2024-02-14 | NDAQ:GLSI) Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01 ....

United States , Baylor College Of Medicine , Nordrhein Westfalen , France General , Baylor University , University Hospital , San Francisco , Jaye Thompson , Miguel Martin , Institut Curie , Gregorio Mara , Joycea Oshaughnessy , Forschungs Gmb , Mothaffarf Rimawi , Francois Clement Bidard , Williamj Gradishar , Saraa Hurvitz , Gruppo Italiano Mammella , Snehal Patel , Paris Saclay University , American Society Of Clinical Oncology , Complutense University , Head Of Breast Cancer Group , Oncology Service , American Association For Cancer Research , Feinberg School Of Medicine At Northwestern University ,

2024-02-13 | TSXV:TELO | Press Release | Telo Genomics Ord Shs

(2024-02-13 | TSXV:TELO) Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients ....

United States , Sherif Louis , Regulation Services Provider , Company Or Telo , Mcgill University , Telo Genomics Corp , Venture Exchange , End Results Program , Newsfile Corp , National Library Of Medicine , Jewish General Hospital , National Library , Globe Newswire , North America , National Institute , Note Regarding Forward Looking , Telo Genomics Ord Shs , Healthcare 37 , Industrials 38 , Biotechnology 121 , Conglomerates 134 , Can 7 , Usa 8 , Dj Industrial Average , Biotechnology 70569 ,

2024-02-13 | NDAQ:CRSP | Press Release | CRISPR Therapeutics AG

(2024-02-13 | NDAQ:CRSP) CRISPR Therapeutics Announces $280 Million Registered Direct Offering ....

City Of , United Kingdom , United States , San Francisco , Rachel Eides , Samarth Kulkarni , Susan Kim , Therapeutics Inc , Exchange Commission , Vertex Pharmaceuticals , Chief Executive Officer , Nobel Prize Winning , Forward Looking Statement , Private Securities Litigation Reform Act , Factors Closecurlydoublequote , Crispr Therapeutics Ag , Healthcare 37 , Biotechnology 121 , Usa 8 , Biotechnology 70569 ,